GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Dexcom, Inc. (DXCM) [hlAlert]

Rating:
Buy DXCM
up 860.45 %

Dexcom, Inc. (DXCM) rated Buy with price target $12.25 by Jefferies & Co

Posted on: Tuesday,  Mar 9, 2010  9:25 AM ET by Jefferies & Co

Jefferies & Co rated Buy Dexcom, Inc. (NASDAQ: DXCM) on 03/09/2010, when the stock price was $9.76. Since
then, Dexcom, Inc. has gained 860.45% as of 01/13/2016's recent price of $93.74.
If you would have followed this Jefferies & Co's recommendation on DXCM, you would have gained 860.45% of your investment in 2136 days.

Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.

Our focus on growing and mid-sized companies enables us to identify unique investment ideas, which can make the difference in a tough market. Jefferies' research effort covers U.S. & International equity, high yield, convertibles, investment grade fixed income and post-reorganization securities, as well as special situations and quantitative research. The more than 120-person team of research professionals covers over 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes and dig deeper to provide in-depth, thought provoking, objective research. Our analysts use a variety of quantitative and qualitative tools, integrating field analysis, proprietary channel checks and ongoing dialogue with the managements of the companies they cover. We utilize the latest technologies to deliver a research product that is timely, differentiated, and tailored to each customer's needs. Regular client access to companies and their management teams is provided through a wide variety of Jefferies hosted industry conferences, company management meetings and on-site tours.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/9/2010 9:25 AM Buy
None
9.76 12.25
as of 12/31/2010
1 Week up  5.80 %
1 Month up  27.77 %
3 Months up  8.92 %
1 YTD up  47.54 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy